During the past decade, Infectious Diseases Association of Houston conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Infectious Diseases Association of Houston" are "HIV Infections" (5 trials), "Cytomegalovirus Infections" (1 trials) and "Cytomegalovirus Retinitis" (1 trials). Many other conditions were trialed in "Infectious Diseases Association of Houston" in a lesser frequency.

Most popular intervention types in "Infectious Diseases Association of Houston" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Ganciclovir" (2 trials), "Abacavir sulfate, Lamivudine and Zidovudine" (1 trials), "Atazanavir" (1 trials), "Didanosine" (1 trials) and "Efavirenz" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infectious Diseases Association of Houston" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Infectious Diseases Association of Houston". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Infectious Diseases Association of Houston, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Infectious Diseases Association of Houston, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".